Securities Class Actions – Page 47 – ClaimsFiler

Case Type: Securities Class Actions

YayYo, Inc. (NASDAQ: YAYO)

According to the Complaint, YayYo, Inc. purports to, through its subsidiaries, operate an online peer-to-peer booking platform that rents standard passenger vehicles to self-employed ridesharing drivers and manages a fleet of standard passenger vehicles to be rented directly to drivers in the ridesharing economy.

According to the Complaint, Momenta Pharmaceuticals, Inc.is a biotechnology company with a validated innovative scientific platform focused on discovering and developing novel therapeutics to treat rare, immunemediated diseases.

According to the Complaint, Spring Bank Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery and development of a novel class of therapeutics using its proprietary small molecule nucleotide platform.

According to the Complaint, Coty Inc.is one of the world’s largest beauty companies. The Company operates three divisions: Coty Consumer Beauty (“Consumer Beauty”) which focuses on color cosmetics, retail hair coloring and styling products, body care and mass fragrances sold primarily in the mass retail channels; Coty Luxury (“Coty Luxury”) which focuses on prestige fragrances and skincare brands; and Coty Professional Beauty (“Coty Professional”) which focuses on servicing nail salon owners and professionals in both hair and nail.

Pfenex Inc. (AMEX: PFNX)

According to the Complaint, Pfenex Inc. is a development and licensing biotechnology company with commercial products focused on leveraging its proprietary protein production platform, Pfenex Expression Technology®, to develop next-generation and novel protein therapeutics to improve existing therapies and create novel therapies for biological targets linked to critical, unmet diseases.

According to the Complaint, Varian Medical Systems, Inc. delivers innovative cancer care technologies and solutions for the Company’s clinical partners around the globe to help them treat millions of patients each year.

According to the Complaint, Fennec Pharmaceuticals Inc. is a biopharmaceutical company that purportedly focuses on the development of PEDMARK, a sodium thiosulfate anhydrous injection, for the prevention of platinum-induced ototoxicity in pediatric cancer patients.

According to the Complaint, Portland General Electric Company is an electric utility that engages in the generation, transmission, distribution, and retail sale of electricity in the state of Oregon. The Company also participates in wholesale markets by purchasing and selling electricity and natural gas to meet the needs of its retail customers.

According to the Complaint, HDFC Bank Limited provides various banking and financial services to individuals and businesses in India, Bahrain, Hong Kong, and Dubai.

According to the Complaint, Neonode Inc. develops optical touch and gesture control solutions for human-machine interface with devices and remote sensing solutions for driver and cabin monitoring features in automotive and other application areas.

According to the Complaint, CNX Midstream Partners LP is a master limited partnership that owns, operates, develops, and acquires gathering and other midstream energy assets to service natural gas production in the Appalachian Basin in Pennsylvania and West Virginia. The Partnership’s assets include natural gas gathering pipelines and compression and dehydration facilities, as well as condensate gathering, collection, separation, and stabilization facilities.

According to the Complaint, On Deck Capital, Inc. offers a range of term loans and lines of credit customized for small business owners. The Company also offers bank clients a technology and services platform that facilitates online lending to small business customers through ODX, a wholly-owned subsidiary.

According to the Complaint, Otelco Inc. provides wireline telecommunications services in Alabama, Maine, Massachusetts, Missouri, New Hampshire, Vermont, and West Virginia.

According to the Complaint, Principia Biopharma Inc. is a late-stage biopharmaceutical company dedicated to bringing transformative therapies to patients with significant unmet medical needs in immune-mediated diseases.

According to the Complaint, Ultra Petroleum Corp. is a petrochemical company focused on developing its natural gas reserves located in southwest Wyoming. Over 80% of the Company’s revenues have historically been derived from the development and sale of natural gas. On May 14, 2020, Ultra Petroleum filed for bankruptcy protection and is not named as a Defendant in the action. Prior to being delisted, Ultra stock traded on NASDAQ under the ticker symbol “UPL.” Ultra shares currently trade over-the-counter under the ticker symbol “UPLCQ.”

According to the Complaint, Progenity, Inc. is a biotechnology company focused on developing and commercializing molecular testing products and precision medicine applications. The Company provides in vitro molecular tests designed to assist parents in making informed decisions related to family planning, pregnancy, and complex disease diagnosis.

According to the Complaint, Fastly, Inc. is the provider of an edge cloud platform. Fastly’s edge cloud platform purportedly enables “customers to create great digital experiences quickly, securely, and reliably by processing, serving, and securing [its] customers’ applications as close to their end-users as possible.”

According to the Complaint, this action stems from a proposed transaction announced on August 3, 2020 (the "Proposed Transaction"), pursuant to which Jernigan Capital, Inc. ("Jernigan" or the "Company") will be acquired by affiliates of NexPoint Advisors, L.P.

We use cookies to improve your overall web experience. By using our website, you consent to the use of cookies in accordance with our Privacy Policy.

OK